Amicus Therapeutics, Inc.
FOLDNASDAQHealthcare
$14.49
+$0.00(+0.00%)
Market Cap$4.5B
P/E Ratio—
52W High$14.5
52W Low$5.51
Amicus Therapeutics, Inc.（FOLD）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FOLD · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.63B | $0.53B | $0.40B | $0.33B | $0.31B |
| Cost of Revenue | $0.08B | $0.05B | $0.04B | $0.04B | $0.03B |
| Gross Profit | $0.55B | $0.48B | $0.36B | $0.29B | $0.27B |
| Gross Margin %(computed) | 87.32% | 89.98% | 90.65% | 88.28% | 88.72% |
| Operating Expenses | |||||
| R&D Expenses | $0.14B | $0.11B | $0.15B | $0.28B | $0.27B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.52B | $0.45B | $0.44B | $0.50B | $0.48B |
| Operating Income | $0.03B | $0.02B | ($0.08B) | ($0.21B) | ($0.21B) |
| Operating Margin %(computed) | 5.44% | 4.71% | -19.33% | -64.43% | -67.57% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.05B | $0.05B | $0.05B | $0.04B | $0.03B |
| Income Before Tax | $0.00B | ($0.03B) | ($0.15B) | ($0.24B) | ($0.24B) |
| Income Tax Expense | $0.03B | $0.03B | $0.00B | ($0.01B) | $0.01B |
| Net Income | ($0.03B) | ($0.06B) | ($0.15B) | ($0.24B) | ($0.25B) |
| Net Margin %(computed) | -4.27% | -10.62% | -37.96% | -71.85% | -81.98% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.09 | $-0.18 | $-0.51 | $-0.82 | $-0.92 |
| Wtd Avg Shares | 0.31B | 0.30B | 0.30B | 0.29B | 0.27B |
| EBITDA | $0.05B | $0.03B | ($0.09B) | ($0.20B) | ($0.20B) |
| EBITDA Margin %(computed) | 8.48% | 5.56% | -23.06% | -60.62% | -66.40% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Amicus Therapeutics, Inc.
关于Amicus Therapeutics, Inc.（FOLD）损益表
Amicus Therapeutics, Inc.（FOLD）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，FOLD实现营收$0.63B，毛利润$0.55B（毛利率87.32%），净利润($0.03B)（净利率-4.27%）。
常见问题
FOLD · 4 问Amicus Therapeutics, Inc.（FOLD）2025财年营收为$0.63B，同比up20.0%。
FOLD revenueFOLD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08